US Stock MarketDetailed Quotes

SNDX Syndax Pharmaceuticals

Watchlist
  • 21.350
  • +1.660+8.43%
Close Nov 6 16:00 ET
  • 21.350
  • 0.0000.00%
Post 20:01 ET
1.82BMarket Cap-5865P/E (TTM)

Syndax Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Syndax Pharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 5, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
8.40M
12.50M
+4.10M
Beat Est.
--
--
+48.83%
EPS
-1.03
-0.98
+0.05
Beat Est.
-40.72%
-34.25%
+4.59%
Analyst Rating
Strong Buy

Nov 6, 2024

Syndax Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 32.000M --
-- 2024/Q4 -- / 40.931M --
Nov 5, 2024 2024/Q3 12.500M / 8.399M --
Aug 1, 2024 2024/Q2 3.500M / 0.000 --
May 8, 2024 2024/Q1 0.000 / 0.000 --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 32.000M--
--2024/Q4-- / 40.931M--
Nov 5, 20242024/Q312.500M / 8.399M--
Aug 1, 20242024/Q23.500M / 0.000--
May 8, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Syndax Pharmaceuticals Earnings Reports

  • Syndax Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 6 05:06

  • Syndax Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 2 04:06

  • Syndax Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 8 19:08

  • Syndax Pharmaceuticals | 10-K: FY2023 Annual Report

    Feb 28 11:50

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 6, 2024

    Strong Buy

    • Buy

      91.67%

    • Hold

      8.33%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data